US 6,660,297 B2 · Nutritional supplement to treat macular degeneration

Abstract

A nutritional or dietary supplement composition that strengthens and promotes retinal health through the prevention, stabilization, reversal and/or treatment of visual acuity loss by reducing the risk of developing late stage or advanced age-related macular degeneration in persons with early age-related macular degeneration. The nutritional or dietary supplement composition may likewise reduce the risk of vision loss associated with the development of cataracts. The essential ingredients of the nutritional or dietary supplement composition are vitamin C, vitamin E, beta-carotene, zinc and copper. The essential ingredients are preferably provided in a tablet form suitable for oral ingestion. Preferably the composition is taken in the form of one or two tablets taken twice daily.

Claims21

Dependent claims

A composition comprising on a daily dosage basis:

approximately 7 to 10 times the RDA of vitamin C;
approximately 13 to 18 times the RDA of vitamin E;
approximately 6 to 10 times the RDA of vitamin A in the form of beta-carotene;
approximately 4 to 7 times the RDA of zinc;
and
at least 1.6 mg copper.

3 more elements

Dependencies are inferred from the claim text.

Facts

Application

09/816,284Filed 23 Mar 2001

Published

US 2002/0182266 A15 Dec 2002

Granted

9 Dec 2003

Term ends

Not estimatedThe source records don’t support an estimate.

Classification18 codes

A61K 33/34
Heavy metals; Compounds thereof: copper; Compounds thereof
A23L 5/44
Using naturally occurring organic dyes or pigments, their artificial duplicates or their derivatives: using carotenoids or xanthophylls
A23L 33/105
Using additives: plant extracts, their artificial duplicates or their derivatives
A23L 33/15
Using additives: vitamins

Nutritional supplement to treat macular degeneration

Life of this patent

Nutritional supplement to treat macular degeneration

Life of this patent

Abstract

Claims21